CD19 and plasma cell myeloma: Induction of apoptosis of CD19+ cells in LPS-activated primary murine splenocytes and hPBMCs is consistent with prior studies showing that proteasome inhibition with broad-spectrum proteasome inhibitors can induce apoptosis in ASCs, as has been shown in multiple myeloma but also normal human plasma cells [28, 31, 51, 52].